Matthew Gall's Net Worth

$574 Thousand

Estimate Recalculated Jun 13, 2024 07:03PM EST

Who is Matthew Gall?

Matthew Gall does not have any significant net worth to report based on the numbers we have. This is based on reported shares in iTeos Therapeutics, Inc..

SEC CIK

Matthew Gall's CIK is 0001816194

Past Insider Trading and Trends

2021 was Matthew Gall's most active year for acquiring shares with 4 total transactions. Matthew Gall's most active month to acquire stocks was the month of February. 2021 was Matthew Gall's most active year for disposing of shares, totalling 2 transactions. Matthew Gall's most active month to dispose stocks was the month of September. 2021 saw Matthew Gall paying a total of $219,329.14 for 115,429 shares, this is the most they've acquired in one year. In 2021 Matthew Gall cashed out on 19,429 shares for a total of $232,250.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

iTeos Therapeutics, Inc. (ITOS) Snapshot price: $9.985

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 7
Form 4
+211.02%
41K
—
—
60.43K
Dec 5
Form 4
+34.65%
5K
$8.37
$41,850.00
19.43K
Oct 12
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
Mar 11
Form 4
-25.73%
-5.00K
$46.45
-$232,250.00
14.43K
Dec 27
Form 4
+288.58%
14.43K
$6.16
$88,882.64
19.43K
Oct 11
Form 4
—
0
—
—
0
Jun 24
Form 4
∞
5K
$26.09
$130,446.50
5K
Jun 16
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found